Cognex Corporation (NASDAQ: CGNX) is a Technology company in the Hardware, Equipment & Parts industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.
| Index | - | P/E | 85.14 | EPS (ttm) | 0.84 | Insider Own | 0.97% | Shs Outstand | 166.42M | Perf Week | 18.49% |
| Market Cap | 11.90B | Forward P/E | 39.65 | EPS next Y | 1.80 | Insider Trans | -10.26% | Shs Float | 158.72M | Perf Month | 2.92% |
| Enterprise Value | 11.68B | PEG | 4.56 | EPS next Q | - | Inst Own | - | Short Float | 5.24% | Perf Quarter | 27.03% |
| Income | 144.00M | P/S | 11.38 | EPS this Y | 78.01% | Inst Trans | - | Short Ratio | 3.49 | Perf Half Y | 79.88% |
| Sales | 1.05B | P/B | 8.05 | EPS next Y | 20.64% | ROA | 7.11% | Short Interest | 8.31M | Perf YTD | 98.78% |
| Book/sh | 8.89 | P/C | 40.08 | EPS next 5Y | 18.69% | ROE | 9.56% | 52W High | 72.88 -1.87% | Perf Year | 76.72% |
| Cash/sh | 1.78 | P/FCF | 45.03 | EPS past 3/5Y | -17.93% -7.42% | ROIC | 7.06% | 52W Low | 34.60 106.71% | Perf 3Y | 32.35% |
| Dividend Est. | 0.34 (0.48%) | EV/EBITDA | 47.48 | Sales past 3/5Y | -0.40% 4.15% | Gross Margin | 68.02% | Volatility | 4.75% 4.43% | Perf 5Y | -15.01% |
| Dividend TTM | 0.34 (0.47%) | EV/Sales | 11.17 | EPS Y/Y TTM | 35.48% | Oper. Margin | 18.76% | ATR (14) | 3.36 | Perf 10Y | 227.92% |
| Dividend Ex-Date | May 21, 2026 | Quick Ratio | 2.84 | Sales Y/Y TTM | 14.32% | Profit Margin | 13.62% | RSI (14) | 64.32 | Recom | 2.55 |
| Dividend Gr. 3/5Y | 7.04% -31.94% | Current Ratio | 3.55 | EPS Q/Q | 112.50% | SMA20 | 12.00% | Beta | 1.49 | Target Price | 71.75 |
| Payout | 38.78% | Debt/Eq | 0.04 | Sales Q/Q | 24.07% | SMA50 | 10.21% | Rel Volume | 1.19 | Prev Close | 67.44 |
| Employees | 2,745 | LT Debt/Eq | 0.04 | Earnings | Aug 05 | SMA200 | 39.54% | Avg Volume | 2.41M | Price | 71.52 |
| IPO Date | Jul 20, 1989 | Option/Short | Yes / Yes | EPS/Sales Surpr. | 36.93% 9.13% | Net Debt/EBITDA | -0.66 | Volume | 2,863,564 | Change | 6.05% |
| Date | Action | Analyst | Rating | Target |
|---|---|---|---|---|
| Jul-02-26 | Reiterated | Truist Securities | Hold | $61 → $71 |
| May-26-26 | Reiterated | UBS | Buy | $70 → $75 |
| May-26-26 | Reiterated | Seaport Global | $75 | |
| May-26-26 | Upgrade | JP Morgan | Neutral → Overweight | |
| May-14-26 | Reiterated | DA Davidson | Neutral | $55 → $62 |
| May-11-26 | Reiterated | Barclays | Overweight | $61 → $75 |
| May-11-26 | Reiterated | Goldman Sachs | Buy | $50 → $80 |
| May-08-26 | Reiterated | Robert W. Baird | $55 → $72 | |
| May-08-26 | Reiterated | Needham | Buy | $57 → $75 |
| May-08-26 | Reiterated | Truist Securities | Hold | $50 → $61 |
Cognex Corporation specializes in machine vision technology, offering solutions that interpret and process visual data to streamline and automate production and logistics operations globally. Their advanced vision systems enable the automated manufacturing and tracking of individual components or finished goods, such as mobile devices, pharmaceutical containers, and automotive parts. This is achieved by precisely locating, recognizing, examining, and gauging items throughout their journey from production to delivery. The company provides a comprehensive software portfolio, including VisionPro, a collection of patented tools for sophisticated development; QuickBuild, an intuitive platform enabling users to create vision applications via a graphical, flowchart interface; and its specialized deep learning vision software. Beyond software, their offerings encompass robust vision sensors for tasks like ensuring component presence and accurate sizing, alongside the versatile In-Sight series of integrated vision systems and sensors. These tools support a variety of critical inspection functions, such as pinpointing part locations, confirming identities, precise dimensioning, validating assembly, and guiding robotics. Another key product is DataMan, their line of image-based barcode readers and verification systems. Cognex serves a diverse clientele across various sectors, including consumer electronics, automotive manufacturing, general consumer goods, food and beverage processing, pharmaceuticals, and medical device production. Their products are distributed directly and through a global network of partners and system integrators. Established in 1981, Cognex Corporation maintains its headquarters in Natick, Massachusetts.
Per-holder 13F data hasn't been ingested for this ticker yet.
| Line Item (USD, M) | TTM — | FY 2025 12/31/2025 | FY 2024 12/31/2024 | FY 2023 12/31/2023 | FY 2022 12/31/2022 | FY 2021 12/31/2021 | FY 2020 12/31/2020 | FY 2019 12/31/2019 | FY 2018 12/31/2018 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,046 | 994 | 915 | 838 | 1,006 | 1,037 | 811 | 726 | 806 | |
| Cost of Goods Sold Incl. D&A | 334 | 329 | 289 | 236 | 284 | 277 | 206 | 190 | 206 | |
| Gross Profit | 712 | 665 | 626 | 601 | 722 | 760 | 605 | 536 | 600 | |
| Selling, General and Administrative Excl. Other | 374 | 364 | 371 | 339 | 312 | 309 | 268 | 274 | 263 | |
| Research and Development | 141 | 139 | 140 | 139 | 141 | 135 | 131 | 119 | 116 | |
| Other Operating Expense | 1 | 0 | 0 | -7 | 23 | 1 | 35 | 0 | 0 | |
| Operating Income | 196 | 163 | 115 | 131 | 246 | 315 | 171 | 143 | 221 | |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Unusual Expense | — | — | — | — | — | — | — | — | — | |
| Non-Operating Income (Expense) | 21 | 20 | 16 | 5 | 4 | 4 | 16 | 20 | 13 | |
| Net Income Before Taxes | 217 | 183 | 131 | 135 | 251 | 319 | 187 | 163 | 235 | |
| Income Taxes | 74 | 68 | 25 | 22 | 35 | 39 | 11 | -41 | 15 | |
| Consolidated Net Income | 144 | 114 | 106 | 113 | 216 | 280 | 176 | 204 | 219 | |
| Net Income From Continuing Operations | 144 | 114 | 106 | 113 | 216 | 280 | 176 | 204 | 219 | |
| Net Income | 144 | 114 | 106 | 113 | 216 | 280 | 176 | 204 | 219 | |
| EPS (Recurring) | 0.86 | 0.68 | 0.62 | 0.66 | 1.24 | 1.59 | 1.02 | 1.19 | 1.27 | |
| EPS (Basic, Before Extraordinaries) | 0.86 | 0.68 | 0.62 | 0.66 | 1.24 | 1.59 | 1.02 | 1.19 | 1.27 | |
| EPS (Diluted) | 0.84 | 0.68 | 0.62 | 0.65 | 1.23 | 1.56 | 1.00 | 1.16 | 1.24 | |
| EBITDA | 246 | 214 | 164 | 145 | 288 | 339 | 233 | 168 | 243 | |
| Other After Tax Adjustments | — | — | — | — | — | — | — | — | — | |
| Stock Option Compensation Expense | — | — | — | — | — | — | — | — | — | |
| Price To Earnings Ratio | 85.14 | 52.91 | 57.84 | 64.22 | 38.30 | 49.85 | 80.29 | 48.31 | 31.19 | |
| Price To Sales Ratio | 11.42 | 6.08 | 6.70 | 8.57 | 8.10 | 13.20 | 17.13 | 13.20 | 8.25 | |
| Gross Margin | 68.07 | 66.90 | 68.42 | 71.72 | 71.77 | 73.29 | 74.60 | 73.83 | 74.44 | |
| Operating Margin | 18.74 | 16.40 | 12.57 | 15.63 | 24.45 | 30.38 | 21.09 | 19.70 | 27.42 | |
| Net Margin | 13.77 | 11.47 | 11.58 | 13.48 | 21.47 | 27.00 | 21.70 | 28.10 | 27.17 | |
| Shares Outstanding | 167 | 168 | 171 | 172 | 173 | 176 | 173 | 171 | 172 | |
| Market Capitalization | 11,944 | 6,045 | 6,132 | 7,179 | 8,150 | 13,686 | 13,890 | 9,583 | 6,651 | |
| Operating Lease Expense | — | — | — | — | — | — | — | — | — |
| Insider | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| Long Darren Marc | Vice President | May 27 '26 | Sale | 66.37 | 7,077 | 469,671 | 3,990 | May 28 |
| Long Darren Marc | Vice President | May 27 '26 | Option Exercise | 51.99 | 18,673 | 970,718 | 14,244 | May 28 |
| MACDONALD LAURA ANN | VP and PAO | May 12 '26 | Sale | 65.56 | 25,500 | 1,671,862 | 5,258 | May 12 |
| MACDONALD LAURA ANN | VP and PAO | May 12 '26 | Option Exercise | 49.75 | 41,600 | 2,069,751 | 30,758 | May 12 |
| Fennell Mark | Chief Legal Officer &Secretary | May 11 '26 | Option Exercise | 45.33 | 60,010 | 2,720,416 | 23,159 | May 12 |
| MACDONALD LAURA ANN | VP and PAO | May 11 '26 | Option Exercise | 48.45 | 95,910 | 4,646,995 | 37,470 | May 12 |
| MACDONALD LAURA ANN | VP and PAO | May 11 '26 | Sale | 66.80 | 17,212 | 1,149,799 | 5,258 | May 12 |
| Fennell Mark | Chief Legal Officer &Secretary | May 11 '26 | Sale | 66.89 | 8,863 | 592,828 | 0 | May 12 |
| Fehr Dennis | SVP, Chief Financial Officer | May 06 '26 | Option Exercise | 0.00 | 5,394 | 0 | 17,972 | May 08 |
| MACDONALD LAURA ANN | VP and PAO | Mar 15 '26 | Option Exercise | 0.00 | 368 | 0 | 7,579 | Mar 16 |
| PARROTTE DIANNE M | Director | Mar 02 '26 | Option Exercise | 50.16 | 44,000 | 2,207,215 | 51,831 | Mar 03 |
| PARROTTE DIANNE M | Director | Mar 02 '26 | Sale | 54.00 | 18,400 | 993,600 | 33,431 | Mar 03 |
| Gerst Carl | EVP, Global Sales and Products | Feb 23 '26 | Sale | 55.93 | 10,532 | 589,042 | 0 | Feb 24 |
| Papadimitriou Angelos | Director | Feb 23 '26 | Sale | 55.58 | 4,150 | 230,659 | 16,222 | Feb 24 |
| MACDONALD LAURA ANN | VP and PAO | Feb 21 '26 | Option Exercise | 0.00 | 2,754 | 0 | 8,020 | Feb 24 |